Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Jun;21(6):887–891. doi: 10.1128/aac.21.6.887

In vitro effects of mycophenolic acid and allopurinol against Leishmania tropica in human macrophages.

J D Berman, H K Webster
PMCID: PMC182040  PMID: 7114837

Abstract

The possibility that purine inhibitors or analogs might be effective antileishmanial agents led to the determination of the antileishmanial activity of mycophenolic acid and allopurinol in vitro. The drugs were tested against Leishmania tropica amastigotes (mammalian forms) within human macrophages, a model in which achievable serum concentrations of antileishmanial agents currently in use eliminate approximately 90% of the parasites. Mycophenolic acid, an inhibitor of guanosine nucleotide synthesis from inosinic acid, was shown here to inhibit guanosine nucleotide synthesis in L. tropica promastigotes (insect forms). When tested against L. tropica amastigotes within macrophages, mycophenolic acid eliminated 50% of the parasites at achievable peak human serum levels (20 micrograms/ml) and 40% of the parasites at trough serum levels (1 to 10 micrograms/ml). This demonstrates that an inhibitor of guanosine nucleotide synthesis is partially effective against L. tropica in vitro. The purine analog allopurinol was also tested and was found to eliminate 50% of L. tropica amastigotes in this model. Because mycophenolic acid and allopurinol are partially, but not completely, effective antileishmanial agents in this in vitro model, their in vivo utility remains to be determined by clinical trials.

Full text

PDF
891

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berens R. L., Brun R., Krassner S. M. A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol. 1976 Jun;62(3):360–365. [PubMed] [Google Scholar]
  2. Berens R. L., Marr J. J., Nelson D. J., LaFon S. W. Antileishmanial effect of allopurinol and allopurinol ribonucleoside on intracellular forms of Leishmania donovani. Biochem Pharmacol. 1980 Sep 1;29(17):2397–2398. doi: 10.1016/0006-2952(80)90275-0. [DOI] [PubMed] [Google Scholar]
  3. Berman J. D., Dwyer D. M., Wyler D. J. Multiplication of Leishmania in human macrophages in vitro. Infect Immun. 1979 Oct;26(1):375–379. doi: 10.1128/iai.26.1.375-379.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berman J. D., Wyler D. J. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J Infect Dis. 1980 Jul;142(1):83–86. doi: 10.1093/infdis/142.1.83. [DOI] [PubMed] [Google Scholar]
  5. Brewin T. B., Cole M. P., Jones C. T., Platt D. S., Todd I. D. Mycophenolic acid (NSC-129185): preliminary clinical trials. Cancer Chemother Rep. 1972 Feb;56(1):83–87. [PubMed] [Google Scholar]
  6. Franklin T. J., Cook J. M. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J. 1969 Jul;113(3):515–524. doi: 10.1042/bj1130515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gomez E. C., Menendez L., Frost P. Efficacy of mycophenolic acid for the treatment of psoriasis. J Am Acad Dermatol. 1979 Dec;1(6):531–537. doi: 10.1016/s0190-9622(79)80097-3. [DOI] [PubMed] [Google Scholar]
  8. Hande K., Reed E., Chabner B. Allopurinol kinetics. Clin Pharmacol Ther. 1978 May;23(5):598–605. doi: 10.1002/cpt1978235598. [DOI] [PubMed] [Google Scholar]
  9. Hendricks L. D., Wood D. E., Hajduk M. E. Haemoflagellates: commercially available liquid media for rapid cultivation. Parasitology. 1978 Jun;76(3):309–316. doi: 10.1017/s0031182000048186. [DOI] [PubMed] [Google Scholar]
  10. Jones E. L., Epinette W. W., Hackney V. C., Menendez L., Frost P. Treatment of psoriasis with oral mycophenolic acid. J Invest Dermatol. 1975 Dec;65(6):537–542. doi: 10.1111/1523-1747.ep12610346. [DOI] [PubMed] [Google Scholar]
  11. Kager P. A., Rees P. H., Wellde B. T., Hockmeyer W. T., Lyerly W. H. Allopurinol in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1981;75(4):556–559. doi: 10.1016/0035-9203(81)90198-x. [DOI] [PubMed] [Google Scholar]
  12. Knudtzon S., Nissen N. I. Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep. 1972 Apr;56(2):221–227. [PubMed] [Google Scholar]
  13. Lintrup J., Hyltoft-Petersen P., Knudtzon S., Nissen N. I. Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep. 1972 Apr;56(2):229–235. [PubMed] [Google Scholar]
  14. Lynch W. S., Roenigk H. H., Jr Mycophenolic acid for psoriasis. Arch Dermatol. 1977 Sep;113(9):1203–1208. [PubMed] [Google Scholar]
  15. Mahmoud A. A., Warren K. S. Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis. 1977 Jul;136(1):160–163. doi: 10.1093/infdis/136.1.160. [DOI] [PubMed] [Google Scholar]
  16. Marinari R., Fleischmajer R., Schragger A. H., Rosenthal A. L. Mycophenolic acid in the treatment of psoriasis: long-term administration. Arch Dermatol. 1977 Jul;113(7):930–932. [PubMed] [Google Scholar]
  17. Marr J. J., Berens R. L. Antileishmanial effect of allopurinol. II. Relationship of adenine metabolism in Leishmania species to the action of allopurinol. J Infect Dis. 1977 Dec;136(6):724–732. doi: 10.1093/infdis/136.6.724. [DOI] [PubMed] [Google Scholar]
  18. Matsumoto S. S., Raivio K. O., Seegmiller J. E. Adenine nucleotide degradation during energy depletion in human lymphoblasts. Adenosine accumulation and adenylate energy charge correlation. J Biol Chem. 1979 Sep 25;254(18):8956–8962. [PubMed] [Google Scholar]
  19. Webster H. K., Whaun J. M. Application of simultaneous UV-radioactivity high-performance liquid chromatography to the study of intermediary metabolism. I. Purine nucleotides, nucleosides and bases. J Chromatogr. 1981 May 15;209(2):283–292. doi: 10.1016/s0021-9673(00)81590-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES